152 related articles for article (PubMed ID: 11212264)
1. Glycophosphatidylinositol-anchored protein deficiency as a marker of mutator phenotypes in cancer.
Chen R; Eshleman JR; Brodsky RA; Medof ME
Cancer Res; 2001 Jan; 61(2):654-8. PubMed ID: 11212264
[TBL] [Abstract][Full Text] [Related]
2. Effect of glycosylphosphatidylinositol specific phospholipase D gene expression levels on complement mediated killing of leukemic cells in patients with chronic myeloid leukemia.
Jian-Hua T; Xiao-Jie Z; Yi-Dan W; Wen-Kai L; Wang-Jiao H; Cheng-Hong W; Gui-Yuan L
Clin Chim Acta; 2005 Sep; 359(1-2):115-24. PubMed ID: 15907827
[TBL] [Abstract][Full Text] [Related]
3. Expression of GPI-anchored complement regulatory proteins CD55 and CD59 differentiates two subpopulations of human CD56+ CD3- lymphocytes (NK cells).
Solomon KR; Chan M; Finberg RW
Cell Immunol; 1995 Oct; 165(2):294-301. PubMed ID: 7553895
[TBL] [Abstract][Full Text] [Related]
4. The effect of GPI-anchor deficiency on apoptosis in mice carrying a Piga gene mutation in hematopoietic cells.
Kulkarni S; Bessler M
J Leukoc Biol; 2002 Dec; 72(6):1228-33. PubMed ID: 12488505
[TBL] [Abstract][Full Text] [Related]
5. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
[TBL] [Abstract][Full Text] [Related]
6. Recombinant transmembrane CD59 (CD59-TM) confers complement resistance to GPI-anchored protein defective melanoma cells.
De Nardo C; Fonsatti E; Sigalotti L; Calabrò L; Colizzi F; Cortini E; Coral S; Altomonte M; Maio M
J Cell Physiol; 2002 Feb; 190(2):200-6. PubMed ID: 11807824
[TBL] [Abstract][Full Text] [Related]
7. In vivo mutation assay based on the endogenous Pig-a locus.
Bryce SM; Bemis JC; Dertinger SD
Environ Mol Mutagen; 2008 May; 49(4):256-64. PubMed ID: 18288722
[TBL] [Abstract][Full Text] [Related]
8. Robust in vitro replication of Plasmodium falciparum in glycosyl-phosphatidylinositol-anchored membrane glycoprotein-deficient red blood cells.
Pattanapanyasat K; Walsh DS; Yongvanitchit K; Piyawatthanasakul N; Wanachiwanawin W; Webster HK
Am J Trop Med Hyg; 2003 Oct; 69(4):360-5. PubMed ID: 14640493
[TBL] [Abstract][Full Text] [Related]
9. Important roles of glycosylphosphatidylinositol (GPI)-specific phospholipase D and some GPI-anchored proteins in the pathogenesis of hepatocellular carcinoma.
Tang JH; He WJ; Huang H; Tan CC; Duan Q; Wang KJ; Yuan XY; Zhu XJ
Clin Biochem; 2009 Mar; 42(4-5):400-7. PubMed ID: 19135435
[TBL] [Abstract][Full Text] [Related]
10. Accumulation and persistence of Pig-A mutant peripheral red blood cells following treatment of rats with single and split doses of N-ethyl-N-nitrosourea.
Miura D; Dobrovolsky VN; Kimoto T; Kasahara Y; Heflich RH
Mutat Res; 2009; 677(1-2):86-92. PubMed ID: 19501187
[TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of Clostridium septicum alpha toxin mutants and their use in diagnosing paroxysmal nocturnal hemoglobinuria.
Shin DJ; Lee JJ; Choy HE; Hong Y
Biochem Biophys Res Commun; 2004 Nov; 324(2):753-60. PubMed ID: 15474491
[TBL] [Abstract][Full Text] [Related]
12. Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59.
Clayton A; Harris CL; Court J; Mason MD; Morgan BP
Eur J Immunol; 2003 Feb; 33(2):522-31. PubMed ID: 12645951
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of different flow cytometry-based immunophenotypic methods for the analysis of CD59 and CD55 expression on major peripheral blood cell subsets.
Hernández-Campo PM; Martín-Ayuso M; Almeida J; López A; Orfao A
Cytometry; 2002 Jun; 50(3):191-201. PubMed ID: 12116342
[TBL] [Abstract][Full Text] [Related]
14. Altered lipid raft composition and defective cell death signal transduction in glycosylphosphatidylinositol anchor-deficient PIG-A mutant cells.
Szpurka H; Schade AE; Jankowska AM; Maciejewski JP
Br J Haematol; 2008 Jul; 142(3):413-22. PubMed ID: 18544084
[TBL] [Abstract][Full Text] [Related]
15. Development of an in vivo gene mutation assay using the endogenous Pig-A gene: I. Flow cytometric detection of CD59-negative peripheral red blood cells and CD48-negative spleen T-cells from the rat.
Miura D; Dobrovolsky VN; Kasahara Y; Katsuura Y; Heflich RH
Environ Mol Mutagen; 2008 Oct; 49(8):614-21. PubMed ID: 18626999
[TBL] [Abstract][Full Text] [Related]
16. Deletion of the GPI pre-anchor sequence in human p97--a general approach for generating the soluble form of GPI-linked proteins.
Yang J; Tiong J; Kennard M; Jefferies WA
Protein Expr Purif; 2004 Mar; 34(1):28-48. PubMed ID: 14766298
[TBL] [Abstract][Full Text] [Related]
17. Cell-surface density of complement restriction factors (CD46, CD55, and CD59): oral squamous cell carcinoma versus other solid tumors.
Ravindranath NM; Shuler C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Feb; 103(2):231-9. PubMed ID: 17234541
[TBL] [Abstract][Full Text] [Related]
18. The use of PIG-A as a sentinel gene for the study of the somatic mutation rate and of mutagenic agents in vivo.
Peruzzi B; Araten DJ; Notaro R; Luzzatto L
Mutat Res; 2010; 705(1):3-10. PubMed ID: 20034593
[TBL] [Abstract][Full Text] [Related]
19. Two isoforms of eukaryotic phospholipase C in Paramecium affecting transport and release of GPI-anchored proteins in vivo.
Klöppel C; Müller A; Marker S; Simon M
Eur J Cell Biol; 2009 Oct; 88(10):577-92. PubMed ID: 19541386
[TBL] [Abstract][Full Text] [Related]
20. The in vivo Pig-a gene mutation assay, a potential tool for regulatory safety assessment.
Dobrovolsky VN; Miura D; Heflich RH; Dertinger SD
Environ Mol Mutagen; 2010; 51(8-9):825-35. PubMed ID: 20857433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
